Sensus Healthcare, Inc.(SRTS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,842 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in SRTS
Events flagged as statistical outliers against SRTS's own multi-year baseline — not fixed dollar thresholds.
- Insider cluster2026-08-31
2 insiders bought $563,538 of SRTS in 30 days — 3.9σ above this company's 2-year norm
View source filing → - Insider cluster2026-08-27
2 insiders bought $337,922 of SRTS in 30 days — 3.9σ above this company's 2-year norm
View source filing → - Insider cluster2026-08-24
2 insiders bought $271,240 of SRTS in 30 days — 3.9σ above this company's 2-year norm
View source filing → - Insider cluster2026-08-21
2 insiders bought $158,336 of SRTS in 30 days — 3.9σ above this company's 2-year norm
View source filing →
SRTS Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Sensus Healthcare, Inc. (SRTS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SRTS at 16.4/100 on a 32-signal composite quality model, placing it at rank #2,842 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (4.6) and balance sheet strength (7.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Sensus Healthcare, Inc. reports quarterly revenue of $2.3M, net income of $-8.7M, free cash flow of $-3.1M. Top institutional holders of SRTS by reported 13-F value include Pacific Ridge Capital Partners, VANGUARD CAPITAL MANAGEMENT, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. SRTS trades on the Nasdaq exchange and files with the SEC under CIK 1494891. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SRTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sensus Healthcare, Inc. directly from SEC EDGAR. Sensus Healthcare, Inc.'s 13F Pro composite quality score has ranged between 14 and 74 since 2022, currently 16.4 — a stable long-term trajectory across 60 quarterly and live scoring snapshots.
Revenue
Q2 2026
$2.3M
Net Income
Q2 2026
$-8.7M
Free Cash Flow
Q2 2026
$-3.1M
ROIC
Q2 2026
-34.5%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-34.3% YoYNet Income
-216.1% YoYOperating Income
-227.4% YoYEPS (Diluted)
-214.6% YoYTotal Assets
-14.7% YoYOp. Cash Flow
+163.5% YoYFree Cash Flow
+130.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $27.5M -34.3% | $41.8M +71.3% | $24.4M -45.2% | $44.5M +64.7% | $27.0M +182.4% | $9.6M |
| Net Income | $-7.7M -216.1% | $6.6M +1270.5% | $485.0K -98.0% | $24.2M +488.6% | $4.1M +160.3% | $-6.8M |
| Operating Income | $-10.3M -227.4% | $8.1M +2217.8% | $-382.0K -102.6% | $14.8M +260.0% | $4.1M +150.0% | $-8.2M |
| EPS (Diluted) | $-0.47 -214.6% | $0.41 +1266.7% | $0.03 -97.9% | $1.46 +484.0% | $0.25 +159.5% | $-0.42 |
| Total Assets | $53.0M -14.7% | $62.2M +15.7% | $53.7M -5.3% | $56.7M +76.0% | $32.2M +15.1% | $28.0M |
| Operating Cash Flow | $528.0K +163.5% | $-831.0K +61.3% | $-2.1M -51.9% | $-1.4M -393.7% | $-286.0K +34.1% | $-434.0K |
| Free Cash Flow | $332.0K +130.0% | $-1.1M +53.4% | $-2.4M -51.1% | $-1.6M -279.5% | $-414.0K +47.8% | $-793.0K |
Get alerted when SRTS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Sensus Healthcare, Inc. including:
Top Institutional Holders of SRTS
Pacific Ridge Capital Partners, LLC
$2.4M789,675 shVANGUARD CAPITAL MANAGEMENT LLC
$2.0M660,402 shDIMENSIONAL FUND ADVISORS LP
$954.8K316,121 shDivisadero Street Capital Management, LP
$841.0K278,485 shRENAISSANCE TECHNOLOGIES LLC
$731.8K242,334 shGEODE CAPITAL MANAGEMENT, LLC
$465.7K154,152 shUBS Group AG
$460.8K152,573 shSachetta, LLC
$459.1K152,008 shGreenline Wealth Management LLC
$388.9K128,774 shNorth Star Investment Management Corp.
$379.3K125,586 sh
| Fund | Value | Shares |
|---|---|---|
| Pacific Ridge Capital Partners, LLC | $2.4M | 789,675 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.0M | 660,402 |
| DIMENSIONAL FUND ADVISORS LP | $954.8K | 316,121 |
| Divisadero Street Capital Management, LP | $841.0K | 278,485 |
| RENAISSANCE TECHNOLOGIES LLC | $731.8K | 242,334 |
| GEODE CAPITAL MANAGEMENT, LLC | $465.7K | 154,152 |
| UBS Group AG | $460.8K | 152,573 |
| Sachetta, LLC | $459.1K | 152,008 |
| Greenline Wealth Management LLC | $388.9K | 128,774 |
| North Star Investment Management Corp. | $379.3K | 125,586 |
Companies Similar to SRTS
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
ASCENT INDUSTRIES CO.
PETMED EXPRESS INC
Xtant Medical Holdings, Inc.
DarioHealth Corp.
LAKELAND INDUSTRIES INC
Inogen Inc
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put SRTS on your watchlist
Track score changes the day Sensus Healthcare, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SRTS a good stock to buy?
13F Pro's AI-powered analysis of Sensus Healthcare, Inc. (SRTS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SRTS are available on the SRTS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SRTS is classified as a small company.
Which hedge funds own SRTS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SRTS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Sensus Healthcare, Inc.'s investment landscape.